A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

Jones heads to Oz to woo mining investors
Primary Sector

Jones heads to Oz to woo mining investors

Work has begun on a critical minerals list and stocktake.

Ian Llewellyn 03 Jul 2024
Litigation 'may have' disrupted BX Foods' timely accounts filing
Primary Sector

Litigation 'may have' disrupted BX Foods' timely accounts filing

The company was more than a year late in filing its 2022 accounts.

Riley Kennedy 03 Jul 2024